TY  - CONF
T1  - Glaucoma Prognostication Platform
A1  - Aristotelis, Agianniotis
A1  - Alemu, Dawit
A1  - Genoud, Dominique
A1  - Gisler, Christophe
A1  - Hennebert, Jean
A1  - Varidel, Thierry
JA  - Applied Machine Learning Days 2017
Y1  - 2017
T2  - Applied Machine Learning Days 2017, EPFL
CY  - Lausanne, Switzerland
KW  - Classification
KW  - clustering
KW  - feature selection
KW  - glaucoma
KW  - glaucoma prognostication platform
KW  - machine learning
KW  - Triggerfish
N2  - More than 80 million people worldwide suffer from glaucoma, an asymptomatic and irreversible disease of the optic nerve leading to blindness unless intra-ocular pressure (IOP) is controlled. IOP is the only controllable risk factor to stabilize patients, and various therapeutic options exist to reduce IOP. IOP follows, however, individual nycthemeral patterns and cannot be effectively monitored with current devices leading to therapeutic failure and progression visual function loss amongst about one in three glaucoma patients. SENSIMED AG has developed Triggerfish, a wearable non-invasive solution that captures spontaneous dimensional changes at the corneoscleral area. The purpose of the Glaucoma Prognostication Platform is to provide a machine learning platform for 24h profiles of ocular dimensional changes to predict the progression of glaucoma.
ER  -